These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection. Bartlett JG. Clin Infect Dis; 2008 May 15; 46(10):1489-92. PubMed ID: 18419480 [No Abstract] [Full Text] [Related]
16. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027. Pépin J, Valiquette L, Gagnon S, Routhier S, Brazeau I. Am J Gastroenterol; 2007 Dec 01; 102(12):2781-8. PubMed ID: 17900327 [Abstract] [Full Text] [Related]
17. [Assessment of susceptibility to metronidazole and vancomycin of Clostridium difficile strains isolated between 1998-2002]. Pituch H, Obuch-Woszczatyński P, Glinka D, Łazińska B, Meisel-Mikołajczyk F, Łuczak M. Med Dosw Mikrobiol; 2003 Dec 01; 55(3):253-8. PubMed ID: 14702667 [Abstract] [Full Text] [Related]
18. Clostridium difficile-associated disease. Heins JR. S D Med; 2006 Dec 01; 59(12):515-7. PubMed ID: 17212182 [No Abstract] [Full Text] [Related]